Moore (I950) considers that there is no justification now for describing hypochromic anaemia as idiopathic because iron deficiency never develops unless iron is lost from the body in repeated pregnancies, chronic haemorrhage or normal menstruation. In this paper, however, the description of idiopathic has been given to those cases in which hypochromic anaemia is the primary diagnosis, in order to distinguish them from those cases in which the anaemia is obviously secondary to some other disease.
Moore (I950) considers that there is no justification now for describing hypochromic anaemia as idiopathic because iron deficiency never develops unless iron is lost from the body in repeated pregnancies, chronic haemorrhage or normal menstruation. In this paper, however, the description of idiopathic has been given to those cases in which hypochromic anaemia is the primary diagnosis, in order to distinguish them from those cases in which the anaemia is obviously secondary to some other disease.
The credit for first emphasizing the value of iron therapy in chlorosis belongs to Sydenham (1692), but Blaud (I832) raised iron to its status as the specific treatment of chlorosis. Blaud pointed out that in order to prevent relapse the iron treatment should be continued for some time after the cure, and Allbutt (I909) observed the tendency for chlorosis to relapse in later life.
In the disease, which has been variously described as simple achlorhydric anaemia (Witts, 1930) , primary hypochromic anaemia (Damashek, 1933) and idiopathic hypochromic anaemia (Wintrobe and Beebe, I933), the respective authors all found that although the immediate results of iron therapy were good, the late results were most unsatisfactory, and this was because of the tendency to relapse when treatment was stopped. Witts (1930) also observed that the poor prognosis as regards recovery of the anaemia was partly due to the fact that women with hypochromic anaemia would tolerate a state of continued ill-health rather than submit to the discipline of treatment. Heath and Patek (I937) found that relapse of the anaemia following the cessation of iron therapy only occurred in patients in whom pathological blood loss, particularly menorrhagia, con- tinued.
On the other hand, Davidson and Fullerton (1938) found that relapse did occur in patients with normal menses, although in patients who had passed the menopause it only occurred if there was some other source of blood loss.
Probably one of the main factors responsible for the different reports on the association between persistent menorrhagia and a relapse is the variable opinion of the amount of blood loss which can be defined as menorrhagia.
Hypochromic anaemia in the absence of haemorrhage is rare in men, but in the small number of cases which have been reported, the prognosis as regards the anaemia has been very good. Burger and Witts (I934) followed up most of their 26 male patients for from one to ten years after the cessation of iron treatment and none relapsed, and Shorthouse and King (I95I) found that out of 20 male patients who were followed up for from three months to two years after stopping treatment, none relapsed.
These previous observations show fairly definitely that the prognosis of idiopathic hypochromic anaemia in men is good, and that after correcting the anaemia further iron therapy is not required. In women, who form the majority of these patients, however, the prognosis after cessation of iron therapy cannot be predicted with certainty.
Both continuous iron therapy (Witts, 1930; Damashek, 1933) and periodical treatment with large doses of iron (Meulengracht, 1932) have been advocated. As a relapse is by no means invariable, Davidson and Fullerton (1938) considered that it was not necessary to order iron routinely for the prevention of a relapse in women past the menopause, and in pre-menopausal women without menorrhagia iron treatment need not be continued, provided that the patients were examined at six-monthly intervals. It is the fact that a relapse after the cessation of iron therapy is unpredictable which makes the continued treatment of hypochromic anaemia more difficult than that of pernicious anaemia in which a relapse is invariable if the specific treatment is stopped.
Present Investigation
The unsatisfactory results of treatment which have been reported previously, prompted the present investigation to determine whether the prognosis was still poor, and if so, to investigate The original diagnosis was found to be definitely wrong in six patients. One patient had frequent atta,cks of melaena due to bleeding from a stomal ulcer shortly after attending with anaemia. In one patient a chest X-ray, which was taken at another hospital five months after her first attendance, showed evidence of active pulmonary tuberculosis; this mistaken diagnosis, however, could not have been avoided because a chest X-ray, taken at the time of her original attendance, was normal. Four patients were reported to have died from carcinoma of the stomach within two years of attending with anaemia, although the diagnosis was confirmed by post-mortem examination in only one patient; two of these patients had had barium meal X-rays, both of which were normal. Other conditions which became evident after first attending with anaemia were gastrointestinal bleeding in two patients and chronic nephritis and haematuria in one patient respectively. It is not at all certain, however, that these conditions were present when the patients first attended with anaemia.
The prognosis as regards life was good, and apart from the four patients with carcinoma of the stomach, only three patients had died. The cause of death in two of these patients was suicide and chronic nephritis respectively, and was obviously not related to the anaemia. The other patient, who had attended originally with the Plummer-Vinson syndrome, died one year later from carcinoma of the pharynx.
There appeared to be a definite psychogenic overlay in a number of female patients, whose symptoms persisted after the anaemia had been corrected. Out of 35 women whose haemoglobin value was 8o per cent. or above at the time of their follow-up attendance, ii still complained of either lassitude or dyspnoea or both. One of these patients had mitral stenosis and one had emphysema to account for their symptoms, but in the remaining patients the symptoms must have been mainly psychogenic. On the other hand, some of the women had no symptoms when their haemoglobin was at a low level. Out of nine patients whose haemoglobin value was below 50 per cent. at the time of their follow-up attendance, two had no symptoms and one felt better although the haemoglobin value had fallen. In addition, out of zz patients whose haemoglobin value was between So and 70 per cent. at the time of their follow-up attendance, five had no symptoms. Psychogenic symptoms were not evident in the male patients, none of whom had any symptoms after the anaemia had been corrected.
In the males the prognosis as regards recovery of the anaemia was good. The haemoglobin value was above 84 per cent. in nine of the ten patients who kept their appointment, and in the other patient the haemoglobin value had risen from so to 66 per cent. although he had never taken any iron. One other patient wrote to say that he was feeling very well and that he was in the Army, and another patient, who did not attend, had been followed-up previously for over a year without relapse. The continuation of iron therapy was not necessary to prevent a relapse, and only two patients had taken iron regularly since leaving hospital. Four patients had not taken any iron for over a year, and four patients had not taken it for several months.
In the females the prognosis as regards recovery of the anaemia was bad. In 36 (53 per cent.) of 67 female patients who were followed-up for over a year, the haemoglobin value was below 75 per cent., and in i8 (27 per cent.) it was below 6o per cent. In iS of these patients the haemoglobin value had either increased or only altered slightly since their previous attendance, but in 2I patients the haemoglobin value had dropped considerably. In four patients (Nos. 44, 6z, 64 and 89) who had attended hospital on several occasions, there was a history of recurrent relapses.
Information about the progress of another 14 female patients was obtained from answers to the questionnaire and from general practitioners' reports. Seven patients said that they had no symptoms, and the general practitioners reported that another three patients did not appear anaemic. Two patients were considered by their general practitioners to be still anaemic, and the husband of another patient, who had previously attended hospital for four years with persistent anaemia, wrote to say that his wife was still anaemic, but that, although he had pleaded with her, she would not take her iron treatment, and she would not attend hospital. The other patient said that she had had a hysterectomy for fibroids, which was confirmed by a letter from another hospital, and that although she was not anaemic now, her dysphagia had persisted. None of the patients in whom the haemoglobin value was below 75 per cent. had been taking iron regularly. They had either stopped taking it altogether as soon as they felt better, or they continued to take it occasionally if they felt the symptoms returning. The details of iron therapy in these patients are shown in Table I . The reasons usually given for stopping treatment were either that they had not been told that prolonged treatment was required, or that they became tired of the frequent long waits in the doctor's surgery to obtain a new prescription. The impression gained, however, was that these reasons were given often as an excuse for indifference, and this applies particularly to those patients who had recurrent relapses and were urged to continue taking the iron treatment.
Seventeen of the 36 patients with a haemoglobin value below 75 per cent. had normal menses and three had menorrhagia. On the other hand, five patients had scanty menses, seven had passed the menopause, one had had a hysterectomy for fibroids, and in three patients the menses had not yet started. The menstrual function in each of these patients is shown in Table I (Nos. 23, 63 and 77) , but that this could not be regarded as a relapse, because the colour index was about one in each case. In I9 patients there was a considerable rise in the haemoglobin value, and in the remaining nine patients the haemoglobin value showed no significant change. Eight of these patients had been taking iron regularly and the remainder either took it sporadically, or had not taken it during at least the previous seven months. The details of iron therapy in each of these patients is shown in Table 2 .
Eighteen of these patients had passed the menopause, two had had a hysterectomy for fibroids, two had scanty menses, seven had normal menses and two had menorrhagia. The menstrual function in each of these patients is shown in Table 2 . These figures show that a considerably larger number of these patients than the number of those who were still anaemic had passed the menopause. On the other hand, four patients (Nos. 6, II, I2 and 69) with normal menses, one patient (No. I8) with scanty menses and one patient (No. 74) with persistent menorrhagia, had not received any iron treatment during at least the previous seven months and yet they had not relapsed. The cessation of menorrhagia was probably partly responsible for two of these patients (Nos. 6 and II) not relapsing, although in both cases the menorrhagia was relieved by correcting the anaemia, and was not due to any local disease in the pelvis.
These figures show that there was not the same tedency to relapse in patients who had passed the menopause, although relapse did occur occa-sionally after the menopause for no apparent reason. Furthermore, although patients who were menstruating usually relapsed if they stopped taking iron, this was not invariable.
Twenty patients had menorrhagia at the time of their first attendance. In seven of these patients the menorrhagia improved with treatment of the anaemia, and although there was a relapse of the anaemia in four patients (Nos. 47, 52, 55 and 70), the menorrhagia did not return. Five (1934) , by Shorthouse and King (i95i) and in the present series has been invariable. Haemorrhage was present in five male patients in the presgent series, but it appeared to be an adequate cause of the anaemia in only one patient. Cessation of the haemorrhage was probably a factor in preventing relapse in two patients who had a haemorrhoidectomy and in one patient who had had his teeth extracted two months before he had originally attended with anaemia. On the other hand, haemorrhage still continued in one patient with haemorrhoids and in one patient with a naevus on his face which was frequently cut by his razor, and this latter patient had not taken any iron during the previous year. The absence of relapse and also the aetiology of the anaemia can, therefore, only be adequately explained in a small number of cases of hypochromic anaemia in male patients.
The main reason for the poor results in the female patients was that only I zper cent. of the patients had been taking iron regularly. The remainder had either not taken any iron at all or only taken it sporadically. In addition, one-third of the female patients were so unreliable that they had not kept their second appointment at the outpatient clinic. Many women appeared to be indifferent about their health, and, as Witts (1930) observed, they would tolerate a state of continued ill-health rather than submit to the discipline of treatment.
Persistent anaemia was usually associated with normal menstruation but, unlike the cases reported by Heath and Patek (I937), not with pathological blood loss. The prognosis in patients who had passed the menopause was good, and at the time of their follow-up attendance 64 per cent. of the patients with a haemoglobin value above 75 per cent. compared with 22 per cent. of the patients with a haemoglobin value below 75 per cent. had passed the menopause. A relapse occurred occasionally, however, in patients who had passed the menopause and in whom there was no clinical evidence of haemorrhage, and on the other hand relapse was not invariable after stopping treatment in patients with persistent menorrhagia. These findings are difficult to explain, but it is postulated that there is a compensatory increase in iron absorption in the patients with menorrhagia.who do not relapse, and that there is inadequate iron absorption in the patients who, without evidence of haemorrhage, relapse after the menopause.
These findings support the view of previous observers that iron treatment need not be continued in post-menopausal women after the anaemia has been corrected. In view, however, of the occasional cases which relapse, and also of the possibility of the anaemia being due to occult bleeding from a neoplasm, it is advisable to re-examine these women at three-monthly intervals during the next year.
As Davidson and Fullerton (1938) have pointed out, it is not necessary to continue iron therapy routinely to prevent relapse in pre-menopausal women, provided they are re-examined at sixmonthly intervals. The majority of pre-menopausal women, however, relapse after the cessation of iron therapy, and the poor results after these patients have been discharged from the hospital out-patient department emphasizes the importance of keeping them under continued surveillance. As these patients are so often indifferent about their health, and most unreliable about taking their treatment, the importance of continuing to take the prescribed dose of iron should be emphasized to them. After the cessation of iron therapy it is so important to follow-up the patients that every effort should be made to contact those patients who do not keep their appointments. Summary An investigation of the prognosis of i io patients with hypochromic anaemia is described.
The prognosis as regards the anaemia is good in male patients and relapse does not occur after stopping iron therapy.
The prognosis as regards the anaemia is poor in female patients. This is because relapse of the anaemia usually occurs in pre-menopausal women after stopping iron treatment, and few women continue to take iron in adequate dosage. Very occasionally relapse occurs in post-menopausal women without any evidence of haemorrhage, and relapse is not completely invariable in women with menorrhagia after stopping iron therapy.
Emphasis is laid on the importance of keeping pre-menopausal women under continued surveillance in order to obtain a good prognosis.
